Dexcom G6 Continuous Glucose Monitoring in Hemodialysis (DEXCOM-HD)

University of California Irvine (UCI)

Status

Active, not recruiting

Conditions

Hemodialysis

Diabetes

Glucose Measurement

Treatments

Device: Dexcom G6 Continuous Glucose Monitor

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT04217161

HS# 2019-5585

Details and patient eligibility

About

This is a pilot study enrolling adult hemodialysis patients with diabetes recruited from the University of California Irvine Medical Center (UCIMC) who will undergo simultaneous measurement of glucose levels using 1) continuous glucose monitor (CGM) measured by a Dexcom G6 device vs. 2) "gold-standard" blood glucose levels using capillary fingerstick or venous blood glucose measurements obtained on a point of care (POC) blood glucose meter. The study will assess Dexcom G6 accuracy by comparing glucose levels on the CGM device vs. blood glucose measurements in the study population.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult hemodialysis patients age 18 years or older
Have a comorbidity of diabetes
Receipt of care from the inpatient University of California Irvine Medical Center nephrology consult service
Expected hospital stay ≥48 hours
Have the ability to directly provide informed consent for participation in the study

Exclusion criteria

Critically-ill patients receiving care in the intensive care unit (ICU) or cardiac care unit (CCU)
Moribund patients expected to die within 48 hours
Presence of any condition deemed by PI's judgment that would seriously limit life expectancy (i.e., poor survival)
Pregnant
Unwilling or unable to provide informed consent